Understanding Ehlers-Danlos Syndrome(EDS): Inside the Genetic Disorders of Connective Tissue. By Mariam Mubarak.

What is EDS?


(EDS) is a group of 13 inherited genetic disorders that disrupt the production or structure of collagen, weakening the body's connective tissues. Collagen acts as the "glue" that supports the skin, joints, blood vessels, and internal organs, and abnormal or defective collagen causes these tissues to become unusually fragile, loose, and stretchy. This also makes patients with EDS more susceptible to injuries, as their joints are often hypermobile (more flexible than normal) and their skin may be unusually stretchy.

                                                        

Why is it important to be educated about EDS?

Being educated about Ehlers-Danlos syndromes (EDS) is vital because it can shorten the often severe diagnostic delay, help prevent medical errors, validate this often invisible illness, reduce medical trauma, and encourage funding for better treatments and future research.


who does it affect?

Ehlers-Danlos syndrome (EDS) is a genetic condition present at birth that can affect people of all genders, races, ethnicities, and geographic locations. However, the way it presents, is recognized, and is diagnosed can vary between different demographic groups and age groups, leading to disparities in diagnosis and access to care.








What Causes eds?

Ehlers-Danlos syndromes (EDS) are caused by defects in the body's connective tissue. The genetic mutations responsible for the 13 types of Ehlers-Danlos syndromes affect genes that produce collagen or other proteins related to collagen. These mutations can change the structure, production, or processing of collagen, as well as proteins that interact with it. Collagen provides structure and strength to connective tissues throughout the body. When collagen is defective or does not function properly, the connective tissues in the skin, joints, bones, blood vessels, and organs become weaker, resulting in the signs and symptoms of EDS.


Symptoms of EDS:

The symptoms of Ehlers-Danlos syndrome (EDS) primarily include extreme joint hypermobility, tissue and skin fragility, and chronic pain. Because EDS is a systemic connective tissue disorder, it can affect almost every organ system in the body. According to the official 2017 International Classification of the Ehlers-Danlos Syndromes, the exact presentation and severity of symptoms vary depending on which of the 13 subtypes an individual has inherited.


Its diagnosis:

The diagnosis of Ehlers-Danlos syndrome (EDS) depends on the subtype. Most of the rarer subtypes can be confirmed through genetic testing, while the most common subtype, hypermobile EDS (hEDS), is diagnosed using a detailed medical history, physical examination, and the 2017 International Classification diagnostic criteria because there is currently no confirmed genetic test for hEDS. As there is no single blood test that can diagnose all types of EDS, doctors use an international medical framework to make an accurate diagnosis.







What is EDS’s treatment?

Sadly, there is currently no cure for Ehlers-Danlos syndrome (EDS). Instead, treatment focuses on preventing joint damage, managing chronic pain, and protecting affected organ systems. Because EDS affects connective tissues throughout the body, treatment often requires a multidisciplinary medical team. Standard treatment approaches include physical therapy and musculoskeletal protection, comprehensive pain management, management of associated or co-occurring conditions, and surgical and cardiovascular precautions when necessary.


Current research:

Current clinical research on Ehlers-Danlos syndrome (EDS) is expanding rapidly, shifting from viewing EDS as primarily a structural connective tissue disorder to recognizing it as a complex, multi-system condition. Researchers are investigating its genetic causes, improving diagnostic methods, developing better treatments, and studying associated conditions to improve patient care. Global initiatives, including those led by The Ehlers-Danlos Society, have played an important role in advancing research and increasing awareness, helping to improve how the medical community understands, diagnoses, and manages these disorders.


Patient impact:

Ehlers-Danlos syndrome (EDS) has a profound, multi-layered impact on a patient's life, affecting physical abilities, emotional well-being, education, work, and daily activities. Many people with EDS experience chronic pain, frequent joint dislocations or subluxations, fatigue, and the psychological challenges of living with a lifelong condition.

For example, Jameela Jamil an actress was diagnosed with hypermobile EDS (hEDS) and frequently speaks on social media about living with the condition and raising awareness of its challenges. Similarly, Sam Lux a youtube content creator was diagnosed with classical EDS (cEDS) and has created videos explaining the diagnostic process, managing frequent joint subluxations, and coping with the psychological effects of chronic illness.



The statistics of EDS:

While standard historical textbooks estimated EDS occurred in 1 in 5,000 people, modern epidemiological data from The Ehlers-Danlos Society Prevalence Registry indicates that when including Hypermobile EDS (hEDS) and Hypermobility Spectrum Disorders (HSD), the combined diagnosis rate is closer to 1 in 500 individuals.


Why awareness matters!

Raising awareness about Ehlers-Danlos syndrome (EDS) is essential because many people experience years of delayed diagnosis due to a lack of understanding of the condition. Greater awareness can help prevent medical errors, improve access to appropriate care, and ensure patients receive the support they need at school, work, and in healthcare settings. It also encourages research funding, leading to better diagnostic methods, improved treatments, and a higher quality of life for people living with EDS.


Conclusion:

Ehlers-Danlos syndrome (EDS) is a group of inherited connective tissue disorders that can affect many parts of the body and significantly impact a person's daily life. Although there is currently no cure, early diagnosis, proper treatment, and ongoing research can help improve quality of life. By increasing awareness and supporting medical research, we can promote earlier diagnoses, better care, and improved outcomes for people living with EDS.


Work cited 

MLA 9th:

  • The Ehlers-Danlos Society

The Ehlers-Danlos Society. The Ehlers-Danlos Society, https://www.ehlers-danlos.com/. Accessed 5 July 2026.

  • Genetic and Rare Diseases Information Center (GARD), NIH

"Ehlers-Danlos Syndrome." Genetic and Rare Diseases Information Center, National Institutes of Health, https://rarediseases.info.nih.gov/diseases/6322/ehlers-danlos-syndrome. Accessed 5 July 2026.

  • National Organization for Rare Disorders (NORD)

"Ehlers-Danlos Syndrome." National Organization for Rare Disorders, 27 Sept. 2021, https://rarediseases.org/rare-diseases/ehlers-danlos-syndrome/. Accessed 5 July 2026.


Comments

Post a Comment

Popular posts from this blog

Understanding Ehlers-Danlos Syndrome (EDS) By: Zella Shanks (Current Campaign)

Image
  Introduction   What is Ehlers-Danlos Syndrome (EDS)? Ehlers-Danlos Syndrome, also known as EDS, is a group of genetic disorders that affect the body’s connective tissues. Connective tissue is found almost everywhere in the body and helps hold everything together, including your own skin, joints, muscles, and blood vessels. People that have Ehlers-Danlos Syndrome have problems with collagen, which is one of the many main proteins that gives connective tissues its strength and flexibility. When collagen doesn’t work the way it’s supposed to, the body’s tissues become weaker and more likely to stretch or to get injured. Why Is It Important?    Even though EDS isn’t very well known, it can have a huge effect on someone’s everyday life. Many people deal with ongoing pain, fatigue, joint injuries, and other symptoms that can make normal activities more difficult. While there isn’t a cure yet, getting diagnosed early and learning how to manage the condition can ...
Read more

Uncovering the Clinical Characterization and Mechanisms of Fibrodysplasia Ossificans Progressiva (FOP) By: Sharen Rego

Image
 Introduction Fibrodysplasia Ossificans Progressiva or FOP is an exceedingly rare, yet severely disabling genetic disorder, characterized by the abnormal formation of bone tissue outside of the normal human skeleton (heterotopic ossification). This can occur within soft tissues like the skeletal muscles, tendons, and ligaments. With an estimated one in two million people affected globally, FOP represents one of the most complex genetic conditions known to modern medicine. Raising awareness for this disorder is crucial, as early symptoms are often misdiagnosed as cancer, leading to harmful medical interventions like biopsies or routine muscle injections which trigger irreversible bone growth. Main Body At the cellular level, FOP is caused by a specific mutation in the ACVR1 gene located on chromosome 2. This gene provides instructions for making a specialized receptor protein that controls when and where the body builds bone tissue (such as during fetal development or when healing a...
Read more

Understanding Cystic Fibrosis

Image
Blog written by Alyza Kour - Reasearch Lead of Teen Med Spot   Mucus in our body is more than just “gross stuff” coming out our nose when we have a cold, it’s actually a vital protective layer. Its job is to line our lungs, digestive tract, and other organs to keep them moist and to trap dust, bacteria, or virusese so your body can get rid of them. Healthy mucus is thin, slippery, and water (Think of it like a layer of liquid soap). ( Cleveland Clinic ) What is cystic fibrosis? It is a genetic disease that causes sticky, thick mucus to build up in your organs (Lungs, Digestive System, Pancreas), blocking and damaging them. ( Cleveland Clinic.org ) What causes cystic fibrosis? Changes to the CFTR gene - called variants or mutations - cause cystic fibrosis. CFTR makes a protein that works as an ion channel on the surface of a cell. Ion channels are like gates in a cell’s membrane that allow certain molecules to pass through. Think of this protein as a “gate” for chloride ions (sa...
Read more